Table 5. Failure patterns of 20 out of the 60 patients who received SMART combined with chemotherapy.
| First sites of failure | No | % |
|---|---|---|
| Distant metastasis | 10 | 16.7 |
| Regional recurrence | 4 | 6.7 |
| Local recurrence | 4 | 6.7 |
| Local and regional recurrence | 1 | 1.7 |
| Regional and distant | 1 | 1.7 |
Abbreviations: EC: esophageal cancer. SMART: simultaneous modulated accelerated radiotherapy.